Last reviewed · How we verify
NCT05314218
The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting
trial testing Electrophysiology catheters and cables in Cardiac Arrhythmia in 168 participants. Completed in 26 May 2023.
25 May 2023
Quick facts
| Lead sponsor | Alcis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 168 |
| Start date | 23 May 2022 |
| Primary completion | 25 May 2023 |
| Estimated completion | 26 May 2023 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Electrophysiology catheters and cables
Conditions studied
- Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
Sponsor
Alcis
Who can join
Adults 18 to 90, any sex, with Cardiac Arrhythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05314218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrhythmia
Currently open trials in the same condition.
- NCT06870175 — Smart Textile ECG Monitoring · NA · recruiting
- NCT07205367 — Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II · NA · active not recruiting
- NCT06490432 — Pattern of Cardiac Arrhythmia in Patients With MASLD · recruiting
- NCT06096246 — Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) · NA · recruiting
- NCT06696170 — CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation · NA · recruiting
Other Alcis trials
Trials by the same sponsor.
- NCT05223985 — EPC Performance Investigation for StereoElectroEncephaloGraphy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05314218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alcis
- Last refreshed: 13 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05314218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing